Eugeen Maria Jozef Jans

Title: The Innovations of Eugeen Maria Jozef Jans

Introduction

Eugeen Maria Jozef Jans is a notable inventor based in Beerse, Belgium. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of opioid receptor modulators. With a total of eight patents to his name, Jans has established himself as a key figure in innovative drug delivery systems.

Latest Patents

Among his latest patents are formulations designed to deter abuse of opioid medications. These include solid dosage formulations containing 5-({[2-Amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1H-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid. These formulations are accompanied by processes for their preparation and administration, showcasing Jans' commitment to addressing the challenges associated with opioid use.

Career Highlights

Jans is currently associated with Allergan Holdings Unlimited Company, where he continues to innovate in the pharmaceutical sector. His work focuses on creating safer and more effective medication options for patients, particularly in the context of pain management.

Collaborations

Throughout his career, Jans has collaborated with talented individuals such as Tim Costello and Jens Jozef Ceulemans. These partnerships have contributed to the advancement of his research and the successful development of his patented formulations.

Conclusion

Eugeen Maria Jozef Jans is a prominent inventor whose work in opioid receptor modulators has the potential to significantly impact the pharmaceutical industry. His dedication to innovation and collaboration underscores the importance of advancing medical science for the benefit of society.